“ Cytodyn,m and its trials continue” Totall
Post# of 148152
Totally agree. A funny thing happened on the way to buyout or partnership or whatever, Seabiscuit (Leronlimab) wins by 4 length’s against War Admiral (Remdesivir). More likely War Admiral might have been hobbled out of the gate and we longs are holding the winning ticket. Good chance while everyone is speculating on company discussions and more time drifts by that we get an urgent bulletin out of Brazil that will add more color to the those discussions.